Who owns ITERUM THERAPEUTICS PL F?

Tip: Access positions for across all investors

Analyze quarterly positions in Iterum Therapeutics Pl F with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Iterum Therapeutics Pl F stock

Who bought or sold ITERUM THERAPEUTICS PL F this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Byrne Asset Management 3.00 $0.999900 100% Dec 2025
 View chart